NHMRC-NIHR Collaborative Research Grant Scheme 2022

Overview

The NHMRC-NIHR Collaborative Research Grant Scheme 2022 supports Australian participation and collaboration in leading international collaborative research through the United Kingdom’s National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA) Programme. The HTA Programme funds independent research about the effectiveness, costs and broader impact of healthcare treatments and tests. NHMRC will invite Australian researchers who are listed on the successful applications submitted during Stage 1 to apply for NHMRC support of the Australian component of the research under the following topics: 22/85 Positive airway pressure therapy in chronic obstructive pulmonary disease-obstructive sleep apnoea overlap syndrome 22/87 Nebulised antibiotics as prophylaxis against respiratory tract infection in the first year after tracheotomy or laryngectomy 22/90 Self-care of children and young people with neurodisability 22/91 Rescue packs in chronic obstructive pulmonary disease 22/92 Withdrawing long term macrolides in bronchiectasis 22/93 The clinical and cost-effectiveness of colesevelam for the treatment of bile acid diarrhoea 22/94 Optimal management of perianal Crohn’s disease For Further information, please refer to the NIHR HTA funding page